MYO18B-AS1

Across TCGA pan-cancer cohorts, MYO18B-AS1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MYO18B-AS1 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher MYO18B-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MYO18B-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and ESCA show a favorable association.

KICH, KIRC, and CHOL are the cancer types where MYO18B-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	All	0.424	0.897	<.001	108	view →
KIRC	OS	Tertile	All	0.742	0.833	<.001	86	view →
CHOL	DFS	Tertile	All	0.028	0.524	<.001	72	view →
DLBC	OS	Median	III,IV	0.393	0.797	.009	33	view →
THCA	OS	Tertile	III,IV	0.864	0.954	.007	15	view →
BLCA	OS	Tertile	All	0.902	0.332	.031	12	view →
ESCA	DFS	Tertile	All	1.000	0.447	.018	9	view →
PCPG	DFS	Tertile	All	0.798	0.932	.010	9	view →
GBM	OS	Tertile	All	0.245	0.429	.034	9	view →
STAD	OS	Tertile	IV	0.682	0.197	.023	9	view →
LIHC	OS	Tertile	II,III,IV	0.361	0.660	.034	9	view →
SKCM	OS	Tertile	II,III,IV	0.183	0.418	.010	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

MYO18B-AS1–KICH (OS)

Open the KICH breakdown →